{"disease":{"id":"acute-respiratory-viral-infections","name":"acute respiratory viral infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02072174","title":"Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT03039621","title":"Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT03707912","title":"Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Materia Medica Holding","has_results":true},{"nct_id":"NCT03830905","title":"Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"PHARMENTERPRISES LLC","has_results":false},{"nct_id":"NCT03455491","title":"Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"PHARMENTERPRISES LLC","has_results":true},{"nct_id":"NCT04682444","title":"Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Joint Stock Company \"Farmak\"","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}